Share
 
Title
Code
Session Type
Venue
Date Time
Co-Chairs:

HIV-associated immunosuppression has been associated with AIDS-defining tumours since the start of the epidemic. As increasing access to HAART is making HIV a chronic manageable disease, long-term morbidities have become even more important for optimal HIV management, including cancer care. This session features presentations from well-recognized international experts on the diverse ways that oncogenesis expresses itself in HIV-infected patients and will address unanswered questions related to the biology and optimal clinical management of HIV malignancies. They will discuss the changing epidemiology of cancer in people living with HIV (PLHIV), the role of key risk factors, expected changes related to clinical presentations, clinical diagnosis, and clinical course of these malignancies and basic research priorities related to prognosis and therapy. The session is targeted at clinicians and other health care professionals. Participants will obtain information that can improve their diagnostic acumen, and can improve clinical care for PLHIV who develop cancer.

14:30
TUSY0801
Introduction
14:35
TUSY0802
Cervical cancer in African women
Nelly Yatich, RCTP-FACES NGO, Kenya
Slides

14:47
TUSY0803
Anal cancer in people with HIV
Andrew Grulich, University of New South Wales, Australia
Slides

14:59
TUSY0804
Pediatric malignancies and HIV: current trends and prospects for treatment
Cristina Stefan, Medical Research Council, South Africa
15:11
TUSY0805
Cancer trends in North America over the past decade
Benigno Rodriguez, Case Western Reserve University, United States
Slides

15:23
TUSY0806
Lymphoma trends in Southern Africa and Europe
Matthias Egger, University of Bern, Switzerland
Slides

15:35
TUSY0807
Moderated discussion

15:55
TUSY0808
Conclusion